Related Articles
CD155/TIGIT, a novel immune checkpoint in human cancers (Review)
Survival analysis with regard to PD‑L1 and CD155 expression in human small cell lung cancer and a comparison with associated receptors
Expression of TIGIT/CD155 and correlations with clinical pathological features in human hepatocellular carcinoma
Pan‑RAF inhibitor LY3009120 is highly synergistic with low‑dose cytarabine, but not azacitidine, in acute myeloid leukemia with <em>RAS</em> mutations
<em>In silico</em> and<em> in vitro</em> study of FLT3 inhibitors and their application in acute myeloid leukemia